_version_ 1783600437008531456
author Guetl, Katharina
Moazedi-Fuerst, Florentine
Rosskopf, Konrad
Brodmann, Marianne
Krause, Robert
Eller, Philipp
Wilhelmer, Patricia
Eisner, Florian
Sareban, Nazanin
Schlenke, Peter
Kessler, Harald H.
Steinmetz, Ivo
Redlberger-Fritz, Monika
Stiasny, Karin
Stradner, Martin
author_facet Guetl, Katharina
Moazedi-Fuerst, Florentine
Rosskopf, Konrad
Brodmann, Marianne
Krause, Robert
Eller, Philipp
Wilhelmer, Patricia
Eisner, Florian
Sareban, Nazanin
Schlenke, Peter
Kessler, Harald H.
Steinmetz, Ivo
Redlberger-Fritz, Monika
Stiasny, Karin
Stradner, Martin
author_sort Guetl, Katharina
collection PubMed
description
format Online
Article
Text
id pubmed-7588793
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd on behalf of The British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-75887932020-10-27 SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia Guetl, Katharina Moazedi-Fuerst, Florentine Rosskopf, Konrad Brodmann, Marianne Krause, Robert Eller, Philipp Wilhelmer, Patricia Eisner, Florian Sareban, Nazanin Schlenke, Peter Kessler, Harald H. Steinmetz, Ivo Redlberger-Fritz, Monika Stiasny, Karin Stradner, Martin J Infect Letter to the Editor Published by Elsevier Ltd on behalf of The British Infection Association. 2021-03 2020-10-27 /pmc/articles/PMC7588793/ /pubmed/33121954 http://dx.doi.org/10.1016/j.jinf.2020.10.025 Text en © 2020 Published by Elsevier Ltd on behalf of The British Infection Association. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Guetl, Katharina
Moazedi-Fuerst, Florentine
Rosskopf, Konrad
Brodmann, Marianne
Krause, Robert
Eller, Philipp
Wilhelmer, Patricia
Eisner, Florian
Sareban, Nazanin
Schlenke, Peter
Kessler, Harald H.
Steinmetz, Ivo
Redlberger-Fritz, Monika
Stiasny, Karin
Stradner, Martin
SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
title SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
title_full SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
title_fullStr SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
title_full_unstemmed SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
title_short SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
title_sort sars-cov-2 positive virus culture 7 weeks after onset of covid-19 in an immunocompromised patient suffering from x chromosome-linked agammaglobulinemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588793/
https://www.ncbi.nlm.nih.gov/pubmed/33121954
http://dx.doi.org/10.1016/j.jinf.2020.10.025
work_keys_str_mv AT guetlkatharina sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT moazedifuerstflorentine sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT rosskopfkonrad sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT brodmannmarianne sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT krauserobert sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT ellerphilipp sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT wilhelmerpatricia sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT eisnerflorian sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT sarebannazanin sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT schlenkepeter sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT kesslerharaldh sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT steinmetzivo sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT redlbergerfritzmonika sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT stiasnykarin sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia
AT stradnermartin sarscov2positivevirusculture7weeksafteronsetofcovid19inanimmunocompromisedpatientsufferingfromxchromosomelinkedagammaglobulinemia